EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The synergistic role of gut microbiota and RNA in metabolic diseases: mechanisms and therapeutic insights

Zhuo Huang, Qinyan Yao, Shuang Ma, Jinjie Zhou, Xiaoxuan Wang, Qingguo Meng, Yaxin Liu, Zihan Yu, Xin Chen

Frontiers in Microbiology · 29.01.2025 · 16

DOI: 10.3389/fmicb.2025.1504395 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 29.01.2025. Verfasst von Zhuo Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin, China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut microbiota plays a pivotal role in human metabolic health by influencing immune responses, digestion, and metabolic homeostasis. Recent research highlights the intricate interactions between gut microbiota and RNA, especially non-coding RNAs, in regulating metabolic processes. Dysbiosis of the gut microbiota has been linked to metabolic disorders such as type 2 diabetes, obesity, metabolic-associated fatty liver disease (MAFLD) and metabolic heart disease. Microbial metabolites, including short-chain fatty acids (SCFAs), modulate RNA expression, influencing lipid metabolism, glucose regulation, and inflammatory responses. Additionally, microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) serve as critical regulators in these processes, with emerging evidence showing that gut-derived metabolites affect post-transcriptional gene regulation. This review synthesizes the current understanding of the gut microbiota-RNA axis and its role in metabolic diseases. By exploring the molecular mechanisms, particularly how gut microbiota-derived signals modulate RNA pathways, the review underscores the potential of targeting this axis for therapeutic interventions. Furthermore, it examines how dysbiosis leads to epigenetic changes such as m6A RNA methylation, contributing to disease pathogenesis. These insights offer a new perspective on the prevention and treatment of metabolic diseases, with potential applications in personalized medicine.

Schlagwörter

Stichwörter der Autor:innen

RNAgut microbiotametabolic diseasesmetabolismmicrobial metabolites

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin, China.
  • Tianjin Institute of Digestive Disease, Tianjin Medical University General Hospital, Tianjin, China.

Zitieren

APA

Huang, Z., Yao, Q., Ma, S., Zhou, J., Wang, X., Meng, Q., Liu, Y., Yu, Z., & Chen, X. (2025). The synergistic role of gut microbiota and RNA in metabolic diseases: mechanisms and therapeutic insights. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1504395

Vancouver

Huang Z, Yao Q, Ma S, Zhou J, Wang X, Meng Q, et al. The synergistic role of gut microbiota and RNA in metabolic diseases: mechanisms and therapeutic insights. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1504395

BibTeX
@article{Huang2025,
  author = {Huang, Zhuo and Yao, Qinyan and Ma, Shuang and Zhou, Jinjie and Wang, Xiaoxuan and Meng, Qingguo and Liu, Yaxin and Yu, Zihan and Chen, Xin},
  title = {The synergistic role of gut microbiota and RNA in metabolic diseases: mechanisms and therapeutic insights},
  journal = {Frontiers in Microbiology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fmicb.2025.1504395}
}
Kostenlos starten →